Amgen, Inc.

Amgen, Inc. is a leading biotechnology company dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Founded in 1980, Amgen has grown to become one of the largest independent biotechnology companies in the world, with a strong commitment to advancing science and improving patient care.

The company focuses on areas of high unmet medical need, particularly in oncology, nephrology, and inflammation. Amgen’s robust pipeline includes a range of biologic therapies that target serious diseases, showcasing its dedication to scientific excellence and innovation.

With a mission to serve patients, Amgen invests heavily in research and development, employing thousands of scientists and researchers who work tirelessly to bring new treatments to market. The company operates state-of-the-art facilities and collaborates with various academic institutions and healthcare organizations to enhance its research capabilities.

Amgen is also committed to sustainability and corporate responsibility, striving to minimize its environmental impact while ensuring access to its medicines for patients around the globe. The company actively engages in community initiatives and partnerships aimed at improving health outcomes.

Core Values:

• Innovation: Pioneering new therapies through cutting-edge research.
• Integrity: Upholding the highest ethical standards in all operations.
• Patient-Centricity: Focusing on the needs and well-being of patients.
• Sustainability: Committing to environmentally responsible practices.

Headquartered in the UK, Amgen continues to expand its global presence, ensuring that its life-changing therapies reach those who need them most. With a vision to be the world’s leading biotechnology company, Amgen remains steadfast in its pursuit of scientific breakthroughs that transform lives.